Compare American Financial Group Inc (AFG) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
American Financial Group Inc vs Regeneron Pharmaceuticals Inc — how do they compare? American Financial Group Inc trades at $141.21 (market cap $11.86B), while Regeneron Pharmaceuticals Inc trades at $662.85 (market cap $70.90B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 6× American Financial Group Inc's market cap, and American Financial Group Inc pays the higher dividend (2.46%). Which is the better fit depends on your goals.
| AFG | REGN | |
|---|---|---|
Market Cap | $11.86B | $70.90B |
Sector | Financials | Health |
52-Week High | $148.71 | $812.27 |
52-Week Low | $122.42 | $542.52 |
Enterprise Value | $12.33B | $64.85B |
Dividend Yield | 2.46% | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Financial Group Inc
American Financial Group Inc is a holding company that is engaged primarily in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. American also has annuity operations that are focused on sales of traditional fixed and fixed-indexed annuities in the education, bank, and individual markets. American's insurance operations are conducted through the Great American Insurance Group. The group writes business in all 50 of the United States, primarily through independent agents and brokers.
Read more on AFG →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
